Physician profile
Diego Velarde
NPI 1215959721
$7,250.65
in general payments reported to CMS, 2019-2025
6 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $263 · 2021: $69.33 · 2024: $6,138 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Travel and Lodging: $373 · Food and Beverage: $186 · Education: $70.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Travel and Lodging | $373.03 |
| Food and Beverage | $185.92 |
| Education | $70.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Distalmotion US | $6,106.00 | 2024 | Dexter L6 Robot |
| Intuitive Surgical, INC. | $892.87 | 2019-2025 | |
| Conmed Corporation | $104.94 | 2019-2025 | Airseal |
| Allergan, INC. | $69.33 | 2021 | |
| Ethicon US, LLC | $58.74 | 2020 | |
| Phathom Pharmaceuticals, INC. | $18.77 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Velarde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.